A 64-year-old woman is admitted to the hospital with severe community-acquired pneumonia. She is empirically started on intravenous vancomycin and piperacillin-tazobactam. On hospital day 3, her sputum culture grows *Streptococcus pneumoniae* that is susceptible to penicillin and ceftriaxone. Despite these results being reported in the electronic health record (EHR), the primary team continues the broad-spectrum regimen for 5 additional days. The patient subsequently develops a *Clostridioides difficile* infection, resulting in a prolonged hospital stay.
During a case review, the primary team states they saw the culture results but continued the empiric regimen because the patient was 'improving and it felt safer not to change course.' The hospital's quality improvement committee is tasked with designing an intervention to ensure timely antibiotic de-escalation for future patients.
According to the hierarchy of intervention effectiveness, which of the following represents the strongest system-level change to prevent this type of error?
- AMandating that all internal medicine physicians complete a targeted educational module on interpreting microbiology culture results.
- BRequiring providers to document their specific rationale for continuing broad-spectrum antibiotics in a mandatory free-text field within the daily progress note.
- Configuring the electronic health record to automatically discontinue empiric broad-spectrum antibiotic orders at 72 hours, requiring a new order to proceed.Answer
- DImplementing a punitive policy that issues formal written reprimands to providers who fail to narrow antibiotic therapy within 48 hours of finalized culture results.
- EEstablishing a standardized protocol that advises maintaining empiric broad-spectrum antibiotics for the entire hospital stay if the patient demonstrates rapid clinical improvement.